HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Macaque models for AIDS vaccine development.

Abstract
Recent vaccine trials utilizing the simian immunodeficiency virus/macaque model of AIDS are beginning to yield clues regarding mechanisms of protective immunity. Although cytotoxic T lymphocyte responses to SIV may play a role in mediating protection against infection, protective immunity appears to correlate best with the development of antibodies able to neutralize primary or heterologous pathogenic viruses. Protection against disease or persistent infection may be achieved in the absence of sterilizing immunity, suggesting that new benchmarks for AIDS vaccines may be in order.
AuthorsR P Johnson
JournalCurrent opinion in immunology (Curr Opin Immunol) Vol. 8 Issue 4 Pg. 554-60 (Aug 1996) ISSN: 0952-7915 [Print] England
PMID8794019 (Publication Type: Journal Article, Review)
Chemical References
  • AIDS Vaccines
Topics
  • AIDS Vaccines (biosynthesis)
  • Acquired Immunodeficiency Syndrome (prevention & control)
  • Animals
  • Disease Models, Animal
  • Macaca
  • Simian Immunodeficiency Virus (immunology)
  • T-Lymphocytes, Cytotoxic (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: